|
1
|
Vu M, Yu J, Awolude OA and Chuang L:
Cervical cancer worldwide. Curr Probl Cancer. 42:457–465. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ou R, Lv J, Zhang Q, Lin F, Zhu L, Huang
F, Li X, Li T, Zhao L, Ren Y and Xu Y: circAMOTL1 Motivates AMOTL1
expression to facilitate cervical cancer growth. Mol Ther Nucleic
Acids. 19:50–60. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ki EY, Lee KH, Park JS and Hur SY: A
clinicopathological review of pulmonary metastasis from uterine
cervical cancer. Cancer Res Treat. 48:266–272. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hwang JH, Yoo HJ, Lim MC, Seo SS, Kang S,
Kim JY and Park SY: Brain metastasis in patients with uterine
cervical cancer. J Obstet Gynaecol Res. 39:287–291. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hong JH, Tsai CS, Lai CH, Chang TC, Wang
CC, Chou HH, Lee SP and Hsueh S: Recurrent squamous cell carcinoma
of cervix after definitive radiotherapy. Int J Radiat Oncol Biol
Phys. 60:249–257. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27:e432016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wendel Naumann R and Leath CA III:
Advances in immunotherapy for cervical cancer. Curr Opin Oncol.
32:481–487. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang A, Farmer E, Wu TC and Hung CF:
Perspectives for therapeutic HPV vaccine development. J Biomed Sci.
23:752016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lopez MS, Baker ES, Maza M, Fontes-Cintra
G, Lopez A, Carvajal JM, Nozar F, Fiol V and Schmeler KM: Cervical
cancer prevention and treatment in Latin America. J Surg Oncol.
115:615–618. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao Y, Liu Y and Chen K: Mechanisms and
clinical application of tetramethylpyrazine (an interesting natural
compound isolated from Ligusticum Wallichii): Current status
and perspective. Oxid Med Cell Longev. 2016:21246382016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi J, Li R, Yang S, Phang Y, Zheng C and
Zhang H: The protective effects and potential mechanisms of
Ligusticum chuanxiong: Focus on anti-inflammatory,
antioxidant, and antiapoptotic activities. Evid Based Complement
Alternat Med. 2020:82059832020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan Z, Zhang J and Yang C: Ligusticum
wallichii extract inhibited the expression of IL-1β after AMI
in Rats. Evid Based Complement Alternat Med. 2014:6203592014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Z and Moghadasian MH: Chemistry,
natural sources, dietary intake and pharmacokinetic properties of
ferulic acid: A review. Food Chem. 109:691–702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu B, Liu M, Liu H, Li W, Tan S, Zhang S
and Fang Y: Meta-analysis of traditional Chinese patent medicine
for ischemic stroke. Stroke. 38:1973–1979. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang P, She G, Yang Y, Li Q, Zhang H, Liu
J, Cao Y, Xu X and Lei H: Synthesis and biological evaluation of
new ligustrazine derivatives as anti-tumor agents. Molecules.
17:4972–4985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin LN, Wang WT and Xu ZJ: Clinical study
on ligustrazine in treating myocardial ischemia and reperfusion
injury. Zhongguo Zhong Xi Yi Jie He Za Zhi. 17:261–263. 1997.(In
Chinese). PubMed/NCBI
|
|
17
|
Zhou Y, Ji Z, Yan W, Zhou Z, Li H and Xiao
Y: Tetramethylpyrazine inhibits prostate cancer progression by
downregulation of forkhead box M1. Oncol Rep. 38:837–842. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang HH, Liu FB, Ruan Z, Zheng J, Su YJ
and Wang J: Tetramethylpyrazine (TMPZ) triggers S-phase arrest and
mitochondria-dependent apoptosis in lung cancer cells. Neoplasma.
65:367–375. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang S, Lei T and Zhang M: The reversal
effect and its mechanisms of tetramethylpyrazine on multidrug
resistance in human bladder cancer. PLoS One. 11:e01577592016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Zhou Z, Ji Z, Yan W, Li H and Yu
X: Tetramethylpyrazine reduces prostate cancer malignancy through
inactivation of the DPP10AS1/CBP/FOXM1 signaling pathway. Int J
Oncol. 57:314–324. 2020.PubMed/NCBI
|
|
21
|
Shen J, Zeng L, Pan L, Yuan S, Wu M and
Kong X: Tetramethylpyrazine regulates breast cancer cell viability,
migration, invasion and apoptosis by affecting the activity of Akt
and caspase-3. Oncol Lett. 15:4557–4563. 2018.PubMed/NCBI
|
|
22
|
Skoda AM, Simovic D, Karin V, Kardum V,
Vranic S and Serman L: The role of the Hedgehog signaling pathway
in cancer: A comprehensive review. Bosn J Basic Med Sci. 18:8–20.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu F, Zhang Y, Sun B, McMahon AP and Wang
Y: Hedgehog signaling: From basic biology to cancer therapy. Cell
Chem Biol. 24:252–280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu J, Cao G, Wu X, Cai H and Cai B:
Tetramethylpyrazine inhibits activation of hepatic stellate cells
through hedgehog signaling pathways in vitro. Biomed Res Int.
2015:6030672015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang C, Lu H, Li J, Xie X, Fan L, Wang D,
Tan W, Wang Y, Lin Z and Yao T: SOX2 regulates radioresistance in
cervical cancer via the hedgehog signaling pathway. Gynecol Oncol.
151:533–541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luan Y, Liu J, Liu X, Xue X, Kong F, Sun
C, Wang J, Liu L and Jia H: Tetramethypyrazine inhibits renal cell
carcinoma cells through inhibition of NKG2D signaling pathways. Int
J Oncol. 49:1704–1712. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng J, Wang C, Liu T, Li J, Wu L, Yu Q,
Li S, Zhou Y, Zhang J, Chen J, et al: Procyanidin B2 inhibits the
activation of hepatic stellate cells and angiogenesis via the
Hedgehog pathway during liver fibrosis. J Cell Mol Med.
23:6479–6493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen X, Li L, He Y, Lv X and Ma J:
Raddeanin A inhibits proliferation, invasion, migration and
promotes apoptosis of cervical cancer cells via regulating
miR-224-3p/Slit2/Robo1 signaling pathway. Aging. 13:7166–7179.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de Sanjosé S, Brotons M and Pavón MA: The
natural history of human papillomavirus infection. Best Pract Res
Clin Obstet Gynaecol. 47:2–13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Menderes G, Black J, Schwab CL and Santin
AD: Immunotherapy and targeted therapy for cervical cancer: An
update. Expert Rev Anticancer Ther. 16:83–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaliff M, Karlsson MG, Sorbe B, Bohr
Mordhorst L, Helenius G and Lillsunde-Larsson G: HPV-negative
tumors in a swedish cohort of cervical cancer. Int J Gynecol
Pathol. 39:279–288. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao S, Zhang Z, Yao Z, Shao J, Chen A,
Zhang F and Zheng S: Tetramethylpyrazine attenuates sinusoidal
angiogenesis via inhibition of hedgehog signaling in liver
fibrosis. IUBMB Life. 69:115–127. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Z, Zou B, Zhang X and Peng X: Eupatilin
regulates proliferation and cell cycle of cervical cancer by
regulating hedgehog signalling pathway. Cell Biochem Funct.
38:428–435. 2020. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang F, Ren CC, Liu L, Chen YN, Yang L,
Zhang XA, Wang XM and Yu FJ: SHH gene silencing suppresses
epithelial-mesenchymal transition, proliferation, invasion, and
migration of cervical cancer cells by repressing the hedgehog
signaling pathway. J Cell Biochem. 119:3829–3842. 2018. View Article : Google Scholar : PubMed/NCBI
|
